Compare Globus Medical Inc. Class A Common Stock (GMED) vs Wix.Com Ltd (WIX) Price & Performance

Globus Medical (GMED) trades at $76.32, showing minimal daily movement with a 0.1% gain. The stock demonstrates strong fundamental performance with consistent earnings beats in recent quarters and robust profitability metrics including 68.55% gross margins and 17.03% net income margins. Technical indicators suggest neutral positioning near key support at $73 with resistance at $74. Recent developments include new product showcases at industry conferences and upcoming Q3 earnings release.

GMED presents a compelling investment case with strong analyst support (72% buy rating) and 25% upside to consensus target of $95.13. The company maintains solid revenue growth trajectory and debt-free balance sheet, though investors should monitor competitive pressures in medical devices and potential margin compression as revenue scales. Near-term catalysts include Q3 earnings results expected November 5, 2026.

WIX trades at $74.31, up 0.18% on the day, with a bearish technical signal from moving averages but neutral oscillators. Revenue growth is strong, reaching $1.99B in 2025, though net income margin turned negative at -8.19% in 2026. The company faces multiple class-action lawsuits filed in September 2026, adding legal overhangs. Analyst consensus remains bullish with a $77.00 price target, but negative equity and volatile cash flows highlight financial instability.

The outlook is mixed: robust revenue growth and analyst support offer upside, but profitability challenges, negative equity, and legal risks pose significant headwinds. Investors should weigh the high P/E of 62.84 against earnings volatility and litigation uncertainties before considering a position.